211 related articles for article (PubMed ID: 18769001)
1. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH
Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
4. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
Pea F; Furlanut M; Negri C; Pavan F; Crapis M; Cristini F; Viale P
Antimicrob Agents Chemother; 2009 May; 53(5):1863-7. PubMed ID: 19223642
[TBL] [Abstract][Full Text] [Related]
5. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
6. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
8. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
Frymoyer A; Guglielmo BJ; Wilson SD; Scarpace SB; Benet LZ; Hersh AL
Pharmacotherapy; 2011 Sep; 31(9):871-6. PubMed ID: 21923588
[TBL] [Abstract][Full Text] [Related]
9. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
10. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
James JK; Palmer SM; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):696-700. PubMed ID: 8851595
[TBL] [Abstract][Full Text] [Related]
11. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.
Bernard L; Vaudaux P; Vuagnat A; Stern R; Rohner P; Pittet D; Schrenzel J; Hoffmeyer P;
Infect Control Hosp Epidemiol; 2003 Sep; 24(9):650-4. PubMed ID: 14510246
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
13. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
[TBL] [Abstract][Full Text] [Related]
14. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
15. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
Pai MP; Mercier RC; Allen SE
Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618
[TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
Jeffres MN; Isakow W; Doherty JA; McKinnon PS; Ritchie DJ; Micek ST; Kollef MH
Chest; 2006 Oct; 130(4):947-55. PubMed ID: 17035423
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
[TBL] [Abstract][Full Text] [Related]
19. Dosing vancomycin in the super obese: less is more.
Crass RL; Dunn R; Hong J; Krop LC; Pai MP
J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
[TBL] [Abstract][Full Text] [Related]
20. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
